Use of a C6 ELISA test to evaluate the efficacy of a whole-cell bacterin for the prevention of naturally transmitted canine borrelia burgdorferi infection

Veterinary Therapeutics

Volumn 3, Issue 4, 2002, Pages

  Levy, Steven ^a   Paxson, Julia ^a  

^a ZOETIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; BORRELIA BURGDORFERI; CANIS FAMILIARIS; IXODIDA;

EID: 79251515797     PISSN: 15283593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Grauer GF, Burgess EC, Cooley AJ, et al: Renal lesions associated with Borrelia burgdorferi infection in a dog. JAVMA 193:237-239, 1988.
2. Kornblatt AN, Urband PH, Steere AC: Arthritis caused by Borrelia burgdorferi in dogs. JAVMA 186:960-964, 1985.
3. Levy SA, Barthold SW, Domback DM, et al: Canine Lyme borreliosis. Compend Contin Educ Pract Vet 15:833-846, 1993.
4. Levy SA, Duray PH: Complete heart block in a dog seropositive for Borrelia burgdorferi. Similarity to human Lyme carditis. J Vet Intern Med 2:138-144, 1988.
5. Levy SA, Dreesen DW: Lyme borreliosis in dogs. Canine Pract 17:5-14, 1992.
6. Levy SA, Lissman BA, Ficke CM: Performance of a Borrelia burgdorferi bacterin in borreliosis-endemic areas. JAVMA 202:1834-1838, 1993.
7. Levy SA, Magnarelli LA: Relationship between development of antibodies to Borrelia burgdorferi in dogs and the subsequent development of limb/joint borreliosis. JAVMA 200:344-347, 1992.
8. Levy SA: Why I vaccinate dogs against infection with Lyme disease. Compend Contin Educ Pract Vet 19:1268-1275, 1997.
9. Magnarelli LA, Anderson JF, Kaufmann AF, et al: Borreliosis in dogs from southern Connecticut. JAVMA 186:955-959, 1985.
10. Magnarelli LA, Anderson JF, Schreier AB, et al: Clinical and serological studies of canine borreliosis. JAVMA 191:1089-1094, 1987.
11. Lissman BA, Bosler EM, Camay H, et al: Spirochete-associated arthritis (Lyme disease) in a dog. JAVMA 185:219-220, 1984.
12. Burgdorfer W, Barbour AG, Hayes SF, et al: Lyme disease-A tick-borne spirochetosis. Science 216:1317-1319, 1982.
13. Steere AC, Grodzicki RL, Kornblatt AN: The spirochetal etiology of Lyme disease. N Engl J Med 308:733-739, 1983.
14. Wasmoen TL, Sebring RW, Blumer BM, et al: Examination of Koch's postulates for Borrelia burgdorferi as the causative agent of limb/joint dysfunction in dogs with borreliosis. JAVMA 201:412-418, 1992.
15. Burgess EC: Natural exposure of Wisconsin dogs to the Lyme disease spirochete (Borrelia burgdorferi). Lab Anim Sci 36:288-290, 1986.
16. Magnarelli LA, Anderson JF, Schreier AB: Persistence of antibodies to Borrelia burgdorferi in dogs of New York and Connecticut. JAVMA 196:1064-1068, 1990.
17. Barthold SW, Levy SA, Fikrig E, et al: Serologic responses of dogs naturally exposed to or vaccinated against Borrelia burgdorferi infection. JAVMA 207:1435-1440, 1995.
18. Chu H-J, Chavez LG, Blumer BM, et al: Immunogenicity and efficacy study of a commercial Borrelia burgdorferi bacterin. JAVMA 201:403-411, 1992.
19. Liang FT, Aberer E, Cinco M, et al: Antigenic conservation of an immunodominant invariable region of the VlsE lipoprotein among European pathogenic genospecies of Borrelia burgdorferi SL. J Infect Dis 182:1455-1462, 2000.
20. Liang FT, Bowers LC, Philipp MT: C-Terminal invariable region domain of VlsE is immunodominant but its antigenicity is scarcely conserved among strains of Lyme disease spirochetes. Infect Immun 69:3224-3231, 2001.
21. Liang FT, Jacobson RH, Straubinger RK, et al: Characterization of a Borrelia burgdorferi VlsE invariable region useful in canine Lyme disease serodiagnosis by enzyme-linked immunosorbent assay. J Clin Microbiol 38:4160-4166, 2000.
22. Liang FT, Philipp MT: Epitope mapping of the immunodominant invariable region of Borrelia burgdorferi VlsE in three host species. Infect Immun 68:2349-2352, 2000.
23. Liang FT, Steere AC, Marques AR, et al: Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE. J Clin Microbiol 37:3990-3996, 1999.
24. Philipp MT, Bowers LC, Fawcett PT, et al: Antibody response to IR , a conserved immunodominant region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and humans. J Infect Dis 184:870-878, 2001.
25. th Triennial Symp Ame Heartworm Soc, in press, 2002.
26. O'Connor TP, Esty KE, Hanscom JL, et al: Dogs vaccinated with common Lyme disease vaccines do not respond to IR , the conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi. J Clin Microbiol, submitted for publication, 2002.
27. Levy SA, O'Connor TP, Hanscom JL, Shields P: Utility of an in-office test kit for determination of infection status of dogs naturally exposed to Borrelia burgdorferi. Vet Ther 3(3):308-315, 2002.
28. Barthold SW, Bockenstadt LK: Passive immunizing activity of sera from mice infected with Borrelia burgdorferi. Infect Immun 61:4696-4702, 1993.
29. Conlon JAR, Mather TN, Guillermo G, et al: Efficacy of a nonadjuvanted, outer surface protein A, recombinant vaccine in dogs after challenge by ticks naturally infected with Borrelia burgdorferi. Vet Ther 1:96-106, 2000.
30. Appel MJG, Allan S, Jacobson RH, et al: Experimental Lyme disease in dogs produces arthritis and persistent infection. J Infect Dis 167:651-664, 1993.
31. Schwan TG, Piesman J, Golde WT, et al: Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc Natl Acad Sci USA 92:2909-2913, 1995.
32. Ohnishi J, Piesman J, de Silva AM: Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks. Proc Natl Acad Sci USA 98:670-675, 2001.